Here's how NCBI.NLM.NIH.GOV makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NCBI . NLM . NIH . GOV {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ncbi.nlm.nih.gov Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://pmc.ncbi.nlm.nih.gov/articles/PMC8036682/, but it redirected us to https://pmc.ncbi.nlm.nih.gov/articles/PMC8036682/. The analysis below is for the second page.

Title[redir]:
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy - PMC
Description:
Cancer onset and progression are promoted by high deregulation of the immune system. Recently, major advances in molecular and clinical cancer immunology have been achieved, offering new agents for the treatment of common tumors, often with ...

Matching Content Categories {📚}

  • Science
  • Health & Fitness
  • Education

Content Management System {📝}

What CMS is ncbi.nlm.nih.gov built with?

Custom-built

No common CMS systems were detected on Ncbi.nlm.nih.gov, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ncbi.nlm.nih.gov audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,005 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ncbi.nlm.nih.gov Make Money? {💸}

We see no obvious way the site makes money.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Ncbi.nlm.nih.gov has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

doi, cancer, pubmed, google, scholar, pmc, article, free, cells, immune, cell, tumor, rna, expression, noncoding, lncrna, lncrnas, rnas, immunotherapy, mirna, wang, role, ncrnas, patients, long, resistance, chen, zhang, mirnas, targeting, martino, response, target, liu, therapeutic, ncrna, multiple, checkpoint, function, carcinoma, pdl, res, inhibition, tme, breast, targets, tassone, tumors, binding, growth,

Topics {✒️}

informed consent statement pdgf-platelet-derived growth factor watson–crick base-pairing rules lncrna-p23154 binds mir-378a-3p rangtp-dependent dsrna-binding protein adult t-cell lymphoma/leukemia crispri-based genome-scale identification a20/c-rel/ctgf signaling release exosomal mir-23a-3p pseudogene olfr29-ps1 promotes inducing rnase-h-mediated degradation mir-34a-based therapeutic approaches t-cell-mediated immune response afap1-as1-directed epigenetic modification b-cell lymphoma exosomes exosome-mediated drug-resistant phenotype tumor exosomal-mir-23a-3p cell-specific microrna-155-deficient mice pro-inflammatory tumor-promoting activity data availability statement fetal liver-derived progenitors nf-κb/stat3 pathways [86] hgf-hepatocyte growth factor egf-epidermal growth factor risk-evaluating scores based anti pd-1/pd-l1 immunotherapy cutaneous t-cell lymphoma anti-pd-l1 mab binding pmc beta search liposomal mir-34a mimic anti-bcma rna aptamer t-cell-based immunotherapy demonstrated anti-metastatic mir-148b [148] k48–polyubiquitination-mediated degradation lna-i-mir-221 exerts tumor-derived serum exosomes lincrna-p21 knockdown induces node-positive bladder cancer nuclear-enriched autosomal transcript1 immune-related lncrna signature immune-related risk score ifn-y-secreting lymphocytes targeting immune-related signature m1 pro-inflammatory phenotype multi-omics integrative approaches t-cell-based therapy aptamer-based therapeutic tool 13-mer lna-inhibitor-mir-221 transcriptome rna-sequencing data esophageal squamous-cell carcinoma

Questions {❓}

  • Long intronic noncoding RNA transcription: Expression noise or expression choice?
  • Mechanisms of Resistance to Immune Checkpoint Blockade: Why Does Checkpoint Inhibitor Immunotherapy Not Work for All Patients?
  • Mir-34: A new weapon against cancer?
  • Non-coding RNAs: Hope or hype?
  • Soluble HLA-G: Are they clinically relevant?

External Links {🔗}(396)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager

Libraries {📚}

  • jQuery
  • jQuery module (jquery-3.6.0)
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • nihcesxway.hub.nih.gov
  • nihcesxway2.hub.nih.gov
  • nihcesxway3.hub.nih.gov
  • nihcesxway4.hub.nih.gov
  • nihcesxway5.hub.nih.gov

Name Servers:

  • dns1-ncbi.ncbi.nlm.nih.gov
  • dns2-ncbi.ncbi.nlm.nih.gov
  • lhcns1.nlm.nih.gov
  • lhcns2.nlm.nih.gov

CDN Services {📦}

  • Ncbi

5.06s.